{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T03:18:39Z","timestamp":1774495119508,"version":"3.50.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,8]]},"DOI":"10.7759\/cureus.43111","type":"journal-article","created":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T07:31:06Z","timestamp":1691479866000},"source":"Crossref","is-referenced-by-count":5,"title":["Miller Fisher Syndrome Associated With COVID-19: A History of Molecular Mimicry and an Up-to-Date Review of the Literature"],"prefix":"10.7759","author":[{"given":"Turan","family":"Poyraz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Peripheral neuritis. The Morrison Lectures, 1932, delivered before the Royal College of Physicians of Edinburgh, May 1932","volume":"39","author":"Collier J","year":"1932","unstructured":"Collier J. Peripheral neuritis. The Morrison Lectures, 1932, delivered before the Royal College of Physicians of Edinburgh, May 1932. Edinb Med J. 1932, 39:601-18.","journal-title":"Edinb Med J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM195607122550201","article-title":"An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia)","volume":"255","author":"Fisher M","year":"1956","unstructured":"Fisher M. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N Engl J Med. 1956, 255:57-65. 10.1056\/NEJM195607122550201","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1086\/513793","article-title":"Clinical and epidemiologic features of Guillain-Barr\u00e9 syndrome","volume":"176 Suppl 2","author":"Hughes RA","year":"1997","unstructured":"Hughes RA, Rees JH. Clinical and epidemiologic features of Guillain-Barr\u00e9 syndrome. J Infect Dis. 1997, 176 Suppl 2:S92-8. 10.1086\/513793","journal-title":"J Infect Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang C","year":"2020","unstructured":"Huang C, Wang Y, Li X, et al.. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020, 395:497-506. 10.1016\/S0140-6736(20)30183-5","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2020.2065","article-title":"Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: a review","volume":"77","author":"Zubair AS","year":"2020","unstructured":"Zubair AS, McAlpine LS, Gardin T, Farhadian S, Kuruvilla DE, Spudich S. Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: a review. JAMA Neurol. 2020, 77:1018-27. 10.1001\/jamaneurol.2020.2065","journal-title":"JAMA Neurol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.35656","article-title":"Miller Fisher syndrome associated with COVID-19: a child case report and an up-to-date review of the literature","volume":"15","author":"Poyraz T","year":"2023","unstructured":"Poyraz T. Miller Fisher syndrome associated with COVID-19: a child case report and an up-to-date review of the literature. Cureus. 2023, 15:e35656. 10.7759\/cureus.35656","journal-title":"Cureus"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2021.07.002","article-title":"Miller Fisher syndrome associated with COVID-19 infection","volume":"123","author":"Raghunathan V","year":"2021","unstructured":"Raghunathan V, Dhaliwal M, Singhi P, Singhi S. Miller Fisher syndrome associated with COVID-19 infection. Pediatr Neurol. 2021, 123:40. 10.1016\/j.pediatrneurol.2021.07.002","journal-title":"Pediatr Neurol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.17712\/nsj.2021.3.20210002","article-title":"Miller Fischer and posterior reversible encephalopathy syndromes post COVID-19 infection","volume":"26","author":"Al Haboob AA","year":"2021","unstructured":"Al Haboob AA. Miller Fischer and posterior reversible encephalopathy syndromes post COVID-19 infection. Neurosciences (Riyadh). 2021, 26:295-9. 10.17712\/nsj.2021.3.20210002","journal-title":"Neurosciences (Riyadh)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.35366\/102968","article-title":"S\u00edndrome de Miller-Fisher asociado a postinfecci\u00f3n por SARS-CoV-2 en un paciente pedi\u00e1trico","volume":"34","author":"Puppo CCJ","year":"2021","unstructured":"Puppo CCJ, Cardoso EHR, Su\u00e1rez HS, Vel\u00e1zquez DPX. S\u00edndrome de Miller-Fisher asociado a postinfecci\u00f3n por SARS-CoV-2 en un paciente pedi\u00e1trico. Rev Latin Infect Pediatr. 2021, 34:183-186. 10.35366\/102968","journal-title":"Rev Latin Infect Pediatr"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/ane.13687","article-title":"Miller Fisher syndrome following COVID-19 vaccines: a scoping review","volume":"146","author":"Kim JE","year":"2022","unstructured":"Kim JE, Yoon BA, Kim YH, Kim JK, Bae JS. Miller Fisher syndrome following COVID-19 vaccines: a scoping review. Acta Neurol Scand. 2022, 146:604-9. 10.1111\/ane.13687","journal-title":"Acta Neurol Scand"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3988\/jcn.2021.17.4.541","article-title":"Miller Fisher syndrome in patients with severe acute respiratory syndrome coronavirus 2 infection: a systematic review","volume":"17","author":"Martins-Filho PR","year":"2021","unstructured":"Martins-Filho PR, Pereira de Andrade AL, Pereira de Andrade AJ, et al.. Miller Fisher syndrome in patients with severe acute respiratory syndrome coronavirus 2 infection: a systematic review. J Clin Neurol. 2021, 17:541-5. 10.3988\/jcn.2021.17.4.541","journal-title":"J Clin Neurol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.56.8.1104","article-title":"Clinical features and prognosis of Miller Fisher syndrome","volume":"56","author":"Mori M","year":"2001","unstructured":"Mori M, Kuwabara S, Fukutake T, Yuki N, Hattori T. Clinical features and prognosis of Miller Fisher syndrome. Neurology. 2001, 56:1104-6. 10.1212\/wnl.56.8.1104","journal-title":"Neurology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-008-0775-0","article-title":"Bickerstaff's brainstem encephalitis and Fisher syndrome form a continuous spectrum: clinical analysis of 581 cases","volume":"255","author":"Ito M","year":"2008","unstructured":"Ito M, Kuwabara S, Odaka M, Misawa S, Koga M, Hirata K, Yuki N. Bickerstaff's brainstem encephalitis and Fisher syndrome form a continuous spectrum: clinical analysis of 581 cases. J Neurol. 2008, 255:674-82. 10.1007\/s00415-008-0775-0","journal-title":"J Neurol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000160399.08456.7C","article-title":"Antecedent infections in Fisher syndrome: a common pathogenesis of molecular mimicry","volume":"64","author":"Koga M","year":"2005","unstructured":"Koga M, Gilbert M, Li J, et al.. Antecedent infections in Fisher syndrome: a common pathogenesis of molecular mimicry. Neurology. 2005, 64:1605-11. 10.1212\/01.WNL.0000160399.08456.7C","journal-title":"Neurology"},{"key":"ref15","article-title":"Anti-GQ1b-positive Miller Fisher syndrome in a patient with acute Epstein-Barr virus infection and negative Campylobacter serology","volume":"40","author":"Schnorf H","year":"1998","unstructured":"Schnorf H, Rathgeb JP, Kohler A. Anti-GQ1b-positive Miller Fisher syndrome in a patient with acute Epstein-Barr virus infection and negative Campylobacter serology. Eur Neurol. 1998, 40:177.","journal-title":"Eur Neurol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-510X(98)00220-2","article-title":"Fisher's syndrome and group A streptococcal infection","volume":"160","author":"Yuki N","year":"1998","unstructured":"Yuki N, Hirata K. Fisher's syndrome and group A streptococcal infection. J Neurol Sci. 1998, 160:64-6. 10.1016\/S0022-510X(98)00220-2","journal-title":"J Neurol Sci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.53.7.615","article-title":"Miller Fisher syndrome associated with Q fever","volume":"53","author":"Diaz Ortu\u00f1o A","year":"1990","unstructured":"Diaz Ortu\u00f1o A, Maeztu C, Mu\u00f1oz JA, Reigadas R, Rodriguez T, Vald\u00e9s M. Miller Fisher syndrome associated with Q fever. J Neurol Neurosurg Psychiatry. 1990, 53:615-6. 10.1136\/jnnp.53.7.615","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2004.044032","article-title":"Miller Fisher syndrome associated with Pasteurella multocida infection","volume":"75","author":"Bennetto LP","year":"2004","unstructured":"Bennetto LP, Lyons P. Miller Fisher syndrome associated with Pasteurella multocida infection. J Neurol Neurosurg Psychiatry. 2004, 75:1786-7. 10.1136\/jnnp.2004.044032","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/BF00919603","article-title":"Fisher's syndrome associated with chickenpox and anti-GQ1b antibody","volume":"242","author":"Takano H","year":"1995","unstructured":"Takano H, Yuki N. Fisher's syndrome associated with chickenpox and anti-GQ1b antibody. J Neurol. 1995, 242:255-6. 10.1007\/BF00919603","journal-title":"J Neurol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000009619","article-title":"Miller Fisher syndrome and polyneuritis cranialis in COVID-19","volume":"95","author":"Guti\u00e9rrez-Ortiz C","year":"2020","unstructured":"Guti\u00e9rrez-Ortiz C, M\u00e9ndez-Guerrero A, Rodrigo-Rey S, et al.. Miller Fisher syndrome and polyneuritis cranialis in COVID-19. Neurology. 2020, 95:e601-5. 10.1212\/WNL.0000000000009619","journal-title":"Neurology"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A6609","article-title":"COVID-19-associated Miller Fisher syndrome: MRI findings","volume":"41","author":"Lantos JE","year":"2020","unstructured":"Lantos JE, Strauss SB, Lin E. COVID-19-associated Miller Fisher syndrome: MRI findings. AJNR Am J Neuroradiol. 2020, 41:1184-6. 10.3174\/ajnr.A6609","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14383","article-title":"Miller-Fisher syndrome after SARS-CoV-2 infection","volume":"27","author":"Reyes-Bueno JA","year":"2020","unstructured":"Reyes-Bueno JA, Garc\u00eda-Trujillo L, Urbaneja P, Ciano-Petersen NL, Postigo-Pozo MJ, Mart\u00ednez-Tom\u00e1s C, Serrano-Castro PJ. Miller-Fisher syndrome after SARS-CoV-2 infection. Eur J Neurol. 2020, 27:1759-61. 10.1111\/ene.14383","journal-title":"Eur J Neurol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2020-236419","article-title":"Miller Fisher syndrome and COVID-19: is there a link?","volume":"13","author":"Ray A","year":"2020","unstructured":"Ray A. Miller Fisher syndrome and COVID-19: is there a link?. BMJ Case Rep. 2020, 13:e236419. 10.1136\/bcr-2020-236419","journal-title":"BMJ Case Rep"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14473","article-title":"Miller-Fisher syndrome after COVID-19: neurochemical markers as an early sign of nervous system involvement","volume":"27","author":"Senel M","year":"2020","unstructured":"Senel M, Abu-Rumeileh S, Michel D, Garibashvili T, Althaus K, Kassubek J, Otto M. Miller-Fisher syndrome after COVID-19: neurochemical markers as an early sign of nervous system involvement. Eur J Neurol. 2020, 27:2378-80. 10.1111\/ene.14473","journal-title":"Eur J Neurol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s13365-020-00858-9","article-title":"Miller Fisher syndrome diagnosis and treatment in a patient with SARS-CoV-2","volume":"26","author":"Manganotti P","year":"2020","unstructured":"Manganotti P, Pesavento V, Buoite Stella A, et al.. Miller Fisher syndrome diagnosis and treatment in a patient with SARS-CoV-2. J Neurovirol. 2020, 26:605-6. 10.1007\/s13365-020-00858-9","journal-title":"J Neurovirol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s00415- 020-09912-2","article-title":"Miller-Fisher like syndrome related to SARS-CoV-2 infection (COVID 19)","volume":"267","author":"Fern\u00e1ndez-Dom\u00ednguez J","year":"2020","unstructured":"Fern\u00e1ndez-Dom\u00ednguez J, Ameijide-Sanluis E, Garc\u00eda-Cabo C, Garc\u00eda-Rodr\u00edguez R, Mateos V. Miller-Fisher like syndrome related to SARS-CoV-2 infection (COVID 19). J Neurol. 2020, 267:2495-6. 10.1007\/s00415- 020-09912-2","journal-title":"J Neurol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000009700","article-title":"COVID-19 presenting with ophthalmoparesis from cranial nerve palsy","volume":"95","author":"Dinkin M","year":"2020","unstructured":"Dinkin M, Gao V, Kahan J, et al.. COVID-19 presenting with ophthalmoparesis from cranial nerve palsy. Neurology. 2020, 95:221-3. 10.1212\/WNL.0000000000009700","journal-title":"Neurology"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-020-04517-z","article-title":"Correction to: new clinical manifestation of COVID-19 related Guillain-Barr\u00e8 syndrome highly responsive to intravenous immunoglobulins: two Italian cases","volume":"41","author":"Assini A","year":"2020","unstructured":"Assini A, Benedetti L, Di Maio S, Schirinzi E, Del Sette M. Correction to: new clinical manifestation of COVID-19 related Guillain-Barr\u00e8 syndrome highly responsive to intravenous immunoglobulins: two Italian cases. Neurol Sci. 2020, 41:2307. 10.1007\/s10072-020-04517-z","journal-title":"Neurol Sci"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.5811\/cpcem.2020.6.48683","article-title":"A case report of acute motor and sensory polyneuropathy as the presenting symptom of SARS-CoV-2","volume":"4","author":"Kopscik MR","year":"2020","unstructured":"Kopscik MR, Giourgas BK, Presley BC. A case report of acute motor and sensory polyneuropathy as the presenting symptom of SARS-CoV-2. Clin Pract Cases Emerg Med. 2020, 4:352-4. 10.5811\/cpcem.2020.6.48683","journal-title":"Clin Pract Cases Emerg Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1097\/CND.0000000000000309","article-title":"Novel Coronavirus (Covid-19)-Associated Guillain-Barr\u00e9 syndrome: case report","volume":"21","author":"Rana S","year":"2020","unstructured":"Rana S, Lima AA, Chandra R, Valeriano J, Desai T, Freiberg W, Small G. Novel Coronavirus (Covid-19)-Associated Guillain-Barr\u00e9 syndrome: case report. J Clin Neuromuscul Dis. 2020, 21:240-2. 10.1097\/CND.0000000000000309","journal-title":"J Clin Neuromuscul Dis"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.17060","article-title":"Miller-Fisher syndrome presenting as facial diplegia with Covid-19 co-infection","volume":"13","author":"Tran C","year":"2021","unstructured":"Tran C, Drury B, Yuen HW, Rosenthal J, Neeki MM. Miller-Fisher syndrome presenting as facial diplegia with Covid-19 co-infection. Cureus. 2021, 13:e17060. 10.7759\/cureus.17060","journal-title":"Cureus"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.12424","article-title":"Miller Fisher syndrome in the COVID-19 era - a novel target antigen calls for novel treatment","volume":"13","author":"Kajani S","year":"2021","unstructured":"Kajani S, Kajani R, Huang CW, Tran T, Liu AK. Miller Fisher syndrome in the COVID-19 era - a novel target antigen calls for novel treatment. Cureus. 2021, 13:e12424. 10.7759\/cureus.12424","journal-title":"Cureus"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.micinf.2022.104954","article-title":"Miller-Fisher syndrome associated with SARS-CoV-2: a case report","volume":"24","author":"Faulkner L","year":"2022","unstructured":"Faulkner L, Scott S, Flint N. Miller-Fisher syndrome associated with SARS-CoV-2: a case report. Microbes Infect. 2022, 24:104954. 10.1016\/j.micinf.2022.104954","journal-title":"Microbes Infect"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.29977","article-title":"Course and treatment of a rare neurological sequelae after COVID-19: Miller Fisher syndrome","volume":"14","author":"Kara S","year":"2022","unstructured":"Kara S, Wilson MA, Youssef P, Nedd K. Course and treatment of a rare neurological sequelae after COVID-19: Miller Fisher syndrome. Cureus. 2022, 14:e29977. 10.7759\/cureus.29977","journal-title":"Cureus"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.24638","article-title":"COVID-19-associated Miller Fisher syndrome with long latency period: a case report","volume":"14","author":"Kuang W","year":"2022","unstructured":"Kuang W, Desai P, Voloshko A, Jayasekara D. COVID-19-associated Miller Fisher syndrome with long latency period: a case report. Cureus. 2022, 14:e24638. 10.7759\/cureus.24638","journal-title":"Cureus"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_1864_21","article-title":"Miller Fisher syndrome associated with COVID 19","volume":"11","author":"Yaqoob A","year":"2022","unstructured":"Yaqoob A, Dar W, Khuja Z, et al.. Miller Fisher syndrome associated with COVID 19. J Family Med Prim Care. 2022, 11:4023-5. 10.4103\/jfmpc.jfmpc_1864_21","journal-title":"J Family Med Prim Care"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.26588","article-title":"COVID-19 presenting as Miller Fisher syndrome in a patient with a history of Guillain-Barr\u00e9 syndrome: a case report","volume":"14","author":"Aldabain L","year":"2022","unstructured":"Aldabain L, Haddaden M, Farooqi R, Alissa M. COVID-19 presenting as Miller Fisher syndrome in a patient with a history of Guillain-Barr\u00e9 syndrome: a case report. Cureus. 2022, 14:e26588. 10.7759\/cureus.26588","journal-title":"Cureus"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1177\/19418744211016709","article-title":"COVID-19 induced Miller Fisher syndrome presenting with autonomic dysfunction: a unique case report and review of literature","volume":"12","author":"Biswas S","year":"2022","unstructured":"Biswas S, Ghosh R, Mandal A, et al.. COVID-19 induced Miller Fisher syndrome presenting with autonomic dysfunction: a unique case report and review of literature. Neurohospitalist. 2022, 12:111-6. 10.1177\/19418744211016709","journal-title":"Neurohospitalist"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-021-03245-y","article-title":"Guillain-Barr\u00e9\/Miller Fisher overlap syndrome in a patient after coronavirus disease-2019 infection: a case report","volume":"16","author":"Mohammadi SM","year":"2022","unstructured":"Mohammadi SM, Abdi R, Karimi Z, Mortazavi F. Guillain-Barr\u00e9\/Miller Fisher overlap syndrome in a patient after coronavirus disease-2019 infection: a case report. J Med Case Rep. 2022, 16:63. 10.1186\/s13256-021-03245-y","journal-title":"J Med Case Rep"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.4321\/s0365-66912008000700008","article-title":"[Miller Fisher syndrome, internal and external ophthalmoplegia after flu vaccination]","volume":"83","author":"Blanco-Marchite CI","year":"2008","unstructured":"Blanco-Marchite CI, Buznego-Su\u00e1rez L, Fag\u00fandez-Vargas MA, M\u00e9ndez-Llatas M, Pozo-Martos P. [Miller Fisher syndrome, internal and external ophthalmoplegia after flu vaccination]. Arch Soc Esp Oftalmol. 2008, 83:433-5. 10.4321\/s0365-66912008000700008","journal-title":"Arch Soc Esp Oftalmol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2008.01.013","article-title":"Miller Fisher syndrome in a 66-year-old female after flu and pneumovax vaccinations","volume":"9","author":"Thaler A","year":"2008","unstructured":"Thaler A. Miller Fisher syndrome in a 66-year-old female after flu and pneumovax vaccinations. J Am Med Dir Assoc. 2008, 9:283-4. 10.1016\/j.jamda.2008.01.013","journal-title":"J Am Med Dir Assoc"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2011.236","article-title":"Postvaccination Miller Fisher syndrome","volume":"68","author":"Shoamanesh A","year":"2011","unstructured":"Shoamanesh A, Chapman K, Traboulsee A. Postvaccination Miller Fisher syndrome. Arch Neurol. 2011, 68:1327-9. 10.1001\/archneurol.2011.236","journal-title":"Arch Neurol"},{"key":"ref43","article-title":"The Miller Fisher syndrome. Review of the literature","volume":"12","author":"Berlit P","year":"1992","unstructured":"Berlit P, Rakicky J. The Miller Fisher syndrome. Review of the literature. J Clin Neuroophthalmol. 1992, 12:57-63.","journal-title":"J Clin Neuroophthalmol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1754.2002.00024.x","article-title":"A child with Miller Fisher syndrome","volume":"38","author":"Garrett J","year":"2002","unstructured":"Garrett J, Ryan P. A child with Miller Fisher syndrome. J Paediatr Child Health. 2002, 38:414-6. 10.1046\/j.1440-1754.2002.00024.x","journal-title":"J Paediatr Child Health"},{"key":"ref45","article-title":"Anti-GQ1b-negative Miller Fisher syndrome presented with one-sided horizontal gaze palsy","volume":"52","author":"Akinci G","year":"2010","unstructured":"Akinci G, Oztura I, Hiz-Kurul S. Anti-GQ1b-negative Miller Fisher syndrome presented with one-sided horizontal gaze palsy. Turk J Pediatr. 2010, 52:317-20.","journal-title":"Turk J Pediatr"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.20717","article-title":"Molecular mimicry: sensitization of Lewis rats with Campylobacter jejuni lipopolysaccharides induces formation of antibody toward GD3 ganglioside","volume":"83","author":"Usuki S","year":"2006","unstructured":"Usuki S, Thompson SA, Rivner MH, Taguchi K, Shibata K, Ariga T, Yu RK. Molecular mimicry: sensitization of Lewis rats with Campylobacter jejuni lipopolysaccharides induces formation of antibody toward GD3 ganglioside. J Neurosci Res. 2006, 83:274-84. 10.1002\/jnr.20717","journal-title":"J Neurosci Res"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2012.06.180","article-title":"G.P.74 Clinical aspects of presynaptic neuromuscular transmission defect in anti-GQ1b IgG antibody-related disorders","volume":"22","author":"Lo YL","year":"2012","unstructured":"Lo YL, Seah A, Lim LL, Leoh TH, Dan YF, Fook-Chong S, Ratnagopal P. G.P.74 Clinical aspects of presynaptic neuromuscular transmission defect in anti-GQ1b IgG antibody-related disorders. Neuromuscular Disorders. 2012, 22:857. 10.1016\/j.nmd.2012.06.180","journal-title":"Neuromuscular Disorders"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(199902)45:2<189::aid-ana9>3.0.co;2-t","article-title":"Miller Fisher anti-GQ1b antibodies: alpha-latrotoxin-like effects on motor end plates","volume":"45","author":"Plomp JJ","year":"1999","unstructured":"Plomp JJ, Molenaar PC, O'Hanlon GM, et al.. Miller Fisher anti-GQ1b antibodies: alpha-latrotoxin-like effects on motor end plates. Ann Neurol. 1999, 45:189-99. 10.1002\/1531-8249(199902)45:2&lt;189::aid-ana9&gt;3.0.co;2-t","journal-title":"Ann Neurol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.2183\/pjab.88.299","article-title":"Guillain-Barr\u00e9 syndrome and anti-ganglioside antibodies: a clinician-scientist's journey","volume":"88","author":"Yuki N","year":"2012","unstructured":"Yuki N. Guillain-Barr\u00e9 syndrome and anti-ganglioside antibodies: a clinician-scientist's journey. Proc Jpn Acad Ser B Phys Biol Sci. 2012, 88:299-326. 10.2183\/pjab.88.299","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-018-0027-2","article-title":"Immune-mediated neuropathies","volume":"4","author":"Kieseier BC","year":"2018","unstructured":"Kieseier BC, Mathey EK, Sommer C, Hartung HP. Immune-mediated neuropathies. Nat Rev Dis Primers. 2018, 4:31. 10.1038\/s41572-018-0027-2","journal-title":"Nat Rev Dis Primers"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(199904)45:4<533::aid-ana19>3.0.co;2-h","article-title":"Special sensory ataxia in Miller Fisher syndrome detected by postural body sway analysis","volume":"45","author":"Kuwabara S","year":"1999","unstructured":"Kuwabara S, Asahina M, Nakajima M, Mori M, Fukutake T, Hattori T, Yuki N. Special sensory ataxia in Miller Fisher syndrome detected by postural body sway analysis. Ann Neurol. 1999, 45:533-6. 10.1002\/1531-8249(199904)45:4&lt;533::aid-ana19&gt;3.0.co;2-h","journal-title":"Ann Neurol"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-011-6360-y","article-title":"GQ1b-seronegative Fisher syndrome: clinical features and new serological markers","volume":"259","author":"Koga M","year":"2012","unstructured":"Koga M, Gilbert M, Takahashi M, Li J, Hirata K, Kanda T, Yuki N. GQ1b-seronegative Fisher syndrome: clinical features and new serological markers. J Neurol. 2012, 259:1366-74. 10.1007\/s00415-011-6360-y","journal-title":"J Neurol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(08)70215-1","article-title":"Clinical features, pathogenesis, and treatment of Guillain-Barr\u00e9 syndrome","volume":"7","author":"van Doorn PA","year":"2008","unstructured":"van Doorn PA, Ruts L, Jacobs BC. Clinical features, pathogenesis, and treatment of Guillain-Barr\u00e9 syndrome. Lancet Neurol. 2008, 7:939-50. 10.1016\/S1474-4422(08)70215-1","journal-title":"Lancet Neurol"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2009.05.020","article-title":"Fisher syndrome and Bickerstaff brainstem encephalitis (Fisher-Bickerstaff syndrome)","volume":"215","author":"Yuki N","year":"2009","unstructured":"Yuki N. Fisher syndrome and Bickerstaff brainstem encephalitis (Fisher-Bickerstaff syndrome). J Neuroimmunol. 2009, 215:1-9. 10.1016\/j.jneuroim.2009.05.020","journal-title":"J Neuroimmunol"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(98)97034-8","article-title":"Fisher syndrome associated with IgG anti-GQ1b antibody following infection by a specific serotype of Campylobacter jejuni","volume":"105","author":"Ohtsuka K","year":"1998","unstructured":"Ohtsuka K, Nakamura Y, Hashimoto M, et al.. Fisher syndrome associated with IgG anti-GQ1b antibody following infection by a specific serotype of Campylobacter jejuni. Ophthalmology. 1998, 105:1281-5. 10.1016\/S0161-6420(98)97034-8","journal-title":"Ophthalmology"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1128\/iai.62.5.2122-2125.1994","article-title":"Lipopolysaccharides from Campylobacter jejuni associated with Guillain-Barr\u00e9 syndrome patients mimic human gangliosides in structure","volume":"62","author":"Aspinall GO","year":"1994","unstructured":"Aspinall GO, Fujimoto S, McDonald AG, Pang H, Kurjanczyk LA, Penner JL. Lipopolysaccharides from Campylobacter jejuni associated with Guillain-Barr\u00e9 syndrome patients mimic human gangliosides in structure. Infect Immun. 1994, 62:2122-5. 10.1128\/iai.62.5.2122-2125.1994","journal-title":"Infect Immun"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2003.11.017","article-title":"Usefulness of anti-GQ1b IgG antibody testing in Fisher syndrome compared with cerebrospinal fluid examination","volume":"148","author":"Nishimoto Y","year":"2004","unstructured":"Nishimoto Y, Odaka M, Hirata K, Yuki N. Usefulness of anti-GQ1b IgG antibody testing in Fisher syndrome compared with cerebrospinal fluid examination. J Neuroimmunol. 2004, 148:200-5. 10.1016\/j.jneuroim.2003.11.017","journal-title":"J Neuroimmunol"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2020.152021","article-title":"SARS-CoV-2 attachment to host cells is possibly mediated via RGD-integrin interaction in a calcium-dependent manner and suggests pulmonary EDTA chelation therapy as a novel treatment for COVID 19","volume":"226","author":"Dakal TC","year":"2021","unstructured":"Dakal TC. SARS-CoV-2 attachment to host cells is possibly mediated via RGD-integrin interaction in a calcium-dependent manner and suggests pulmonary EDTA chelation therapy as a novel treatment for COVID 19. Immunobiology. 2021, 226:152021. 10.1016\/j.imbio.2020.152021","journal-title":"Immunobiology"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1002\/mus.23973","article-title":"Sensory nerves are frequently involved in the spectrum of fisher syndrome","volume":"49","author":"Shahrizaila N","year":"2014","unstructured":"Shahrizaila N, Goh KJ, Kokubun N, Tan AH, Tan CY, Yuki N. Sensory nerves are frequently involved in the spectrum of fisher syndrome. Muscle Nerve. 2014, 49:558-63. 10.1002\/mus.23973","journal-title":"Muscle Nerve"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2011.03445.x","article-title":"Miller Fisher syndrome: brief overview and update with a focus on electrophysiological findings","volume":"19","author":"Ar\u00e1nyi Z","year":"2012","unstructured":"Ar\u00e1nyi Z, Kov\u00e1cs T, Sipos I, Bereczki D. Miller Fisher syndrome: brief overview and update with a focus on electrophysiological findings. Eur J Neurol. 2012, 19:15-20, e1-3. 10.1111\/j.1468-1331.2011.03445.x","journal-title":"Eur J Neurol"},{"key":"ref61","article-title":"[Electrophysiologic study of 10 cases of Miller Fisher syndrome]","volume":"157","author":"Durand MC","year":"2001","unstructured":"Durand MC, Goulon-Go\u00e9au C, Schweitzer A, Ch\u00e9liout-H\u00e9raut F, Raphael JC, Gajdos P. [Electrophysiologic study of 10 cases of Miller Fisher syndrome]. Rev Neurol (Paris). 2001, 157:72-9.","journal-title":"Rev Neurol (Paris)"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1097\/WNO.0b013e3181c2514b","article-title":"The Fisher variant of Guillain-Barr\u00e9 syndrome (Fisher syndrome)","volume":"29","author":"Snyder LA","year":"2009","unstructured":"Snyder LA, Rismondo V, Miller NR. The Fisher variant of Guillain-Barr\u00e9 syndrome (Fisher syndrome). J Neuroophthalmol. 2009, 29:312-24. 10.1097\/WNO.0b013e3181c2514b","journal-title":"J Neuroophthalmol"},{"key":"ref63","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.35.8.1096","article-title":"Plasmapheresis and acute Guillain-Barre syndrome","volume":"35","author":"The Guillain-Barre Syndrome Study Group","year":"1985","unstructured":"The Guillain-Barre Syndrome Study Group. Plasmapheresis and acute Guillain-Barre syndrome. Neurology. 1985, 35:1096-1104.","journal-title":"Neurology"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199204233261705","article-title":"A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barr\u00e9 syndrome","volume":"326","author":"van der Mech\u00e9 FG","year":"1992","unstructured":"van der Mech\u00e9 FG, Schmitz PI, Dutch Guillain-Barr\u00e9 Study Group. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barr\u00e9 syndrome. N Engl J Med. 1992, 326:1123-9. 10.1056\/NEJM199204233261705","journal-title":"N Engl J Med"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.282.6266.778","article-title":"Successful plasmapheresis in the Miller-Fisher syndrome","volume":"282","author":"Littlewood R","year":"1981","unstructured":"Littlewood R, Bajada S. Successful plasmapheresis in the Miller-Fisher syndrome. Br Med J (Clin Res Ed). 1981, 282:778. 10.1136\/bmj.282.6266.778","journal-title":"Br Med J (Clin Res Ed)"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1016\/0387-7604(93)90071-F","article-title":"The use of intravenous immunoglobulin in Miller Fisher syndrome","volume":"15","author":"Arakawa Y","year":"1993","unstructured":"Arakawa Y, Yoshimura M, Kobayashi S, Ichihashi K, Miyao M, Momoi MY, Yanagisawa M. The use of intravenous immunoglobulin in Miller Fisher syndrome. Brain Dev. 1993, 15:231-3. 10.1016\/0387-7604(93)90071-F","journal-title":"Brain Dev"},{"key":"ref67","article-title":"Miller Fisher syndrome","author":"Rocha Cabrero F","year":"2021","unstructured":"Rocha Cabrero F, Morrison EH. Miller Fisher syndrome. StatPearls. StatPearls Publishing, Treasure Island (FL); 2021."},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000258673.31824.61","article-title":"Intravenous immunoglobulin therapy for Miller Fisher syndrome","volume":"68","author":"Mori M","year":"2007","unstructured":"Mori M, Kuwabara S, Fukutake T, Hattori T. Intravenous immunoglobulin therapy for Miller Fisher syndrome. Neurology. 2007, 68:1144-6. 10.1212\/01.wnl.0000258673.31824.61","journal-title":"Neurology"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1002\/mus.20835","article-title":"Clinical and immunological spectrum of the Miller Fisher syndrome","volume":"36","author":"Lo YL","year":"2007","unstructured":"Lo YL. Clinical and immunological spectrum of the Miller Fisher syndrome. Muscle Nerve. 2007, 36:615-27. 10.1002\/mus.20835","journal-title":"Muscle Nerve"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.1048","article-title":"A case of Miller Fisher syndrome and literature review","volume":"9","author":"Bukhari S","year":"2017","unstructured":"Bukhari S, Taboada J. A case of Miller Fisher syndrome and literature review. Cureus. 2017, 9:e1048. 10.7759\/cureus.1048","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/171629-miller-fisher-syndrome-associated-with-covid-19-a-history-of-molecular-mimicry-and-an-up-to-date-review-of-the-literature","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:01:29Z","timestamp":1707508889000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/171629-miller-fisher-syndrome-associated-with-covid-19-a-history-of-molecular-mimicry-and-an-up-to-date-review-of-the-literature"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,8]]},"references-count":70,"URL":"https:\/\/doi.org\/10.7759\/cureus.43111","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,8]]}}}